VSee Health, Inc. (VSEE) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 8.10M USD | Liabilities, Current |
| Cash and equivalents | 454.15K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 2.23M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $8.10M | $454.15K | (m) | $2.23M | (m) | (m) |
| 2026-03-31 | (m) | $11.79M | $1.35M | (m) | $2.67M | (m) | (m) |
| 2025-12-31 | (m) | $16.24M | $5.27M | (m) | $2.52M | (m) | (m) |
| 2025-09-30 | (m) | $23.42M | $472.76K | (m) | $2.58M | (m) | (m) |
| 2025-06-30 | (m) | $23.06M | $291.60K | (m) | $1.62M | (m) | (m) |
| 2025-03-31 | (m) | $21.98M | $410.12K | (m) | $1.85M | (m) | (m) |
| 2024-12-31 | (m) | $19.01M | $326.12K | (m) | $1.72M | (m) | (m) |
| 2024-09-30 | (m) | $19.21M | $2.33M | (m) | $2.61M | (m) | (m) |
| 2024-06-30 | (m) | $22.88M | $1.11M | (m) | $2.51M | (m) | (m) |
| 2024-03-31 | (m) | $8.97M | $724.00 | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $7.98M | $1.86K | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $5.02M | $507.00 | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $5.04M | $30.86K | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $5.01M | $16.33K | (m) | (m) | (m) | (m) |
| 2023-01-01 | (m) | (m) | (m) | (m) | $389.45K | (m) | (m) |
| 2022-12-31 | (m) | $3.30M | $107.00K | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $1.55M | $44.97K | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $635.98K | $191.13K | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $386.36K | $509.72K | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $184.06K | $760.01K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |